Review




Structured Review

Bristol Myers randomisation master code
Randomisation Master Code, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/randomisation+master+code/code+master+randomisation/pmc10621004-1318-14-21
Average 86 stars, based on 1 article reviews
randomisation master code - by Bioz Stars, 2026-11
86/100 stars

Images

Related Articles

Selection:

Article Title: Antioxidants for chronic kidney disease
Article Snippet: Allocation concealment (selection bias) , Low risk , Study reported that the only randomisation master code was held by the Bristol‐Myers Company. No investigator had access to randomisation codes until study termination.

Sequencing:

Article Title: Antioxidants for chronic kidney disease
Article Snippet: Allocation concealment (selection bias) , Low risk , Study reported that the only randomisation master code was held by the Bristol‐Myers Company. No investigator had access to randomisation codes until study termination.

Generated:

Article Title: Antioxidants for chronic kidney disease
Article Snippet: Allocation concealment (selection bias) , Low risk , Study reported that the only randomisation master code was held by the Bristol‐Myers Company. No investigator had access to randomisation codes until study termination.

Introduce:

Article Title: Antioxidants for chronic kidney disease
Article Snippet: Allocation concealment (selection bias) , Low risk , Study reported that the only randomisation master code was held by the Bristol‐Myers Company. No investigator had access to randomisation codes until study termination.

Control:

Article Title: Antioxidants for chronic kidney disease
Article Snippet: Allocation concealment (selection bias) , Low risk , Study reported that the only randomisation master code was held by the Bristol‐Myers Company. No investigator had access to randomisation codes until study termination.

Recombinant:

Article Title: Antioxidants for chronic kidney disease
Article Snippet: Allocation concealment (selection bias) , Low risk , Study reported that the only randomisation master code was held by the Bristol‐Myers Company. No investigator had access to randomisation codes until study termination.

Saline:

Article Title: Antioxidants for chronic kidney disease
Article Snippet: Allocation concealment (selection bias) , Low risk , Study reported that the only randomisation master code was held by the Bristol‐Myers Company. No investigator had access to randomisation codes until study termination.

Transplantation Assay:

Article Title: Antioxidants for chronic kidney disease
Article Snippet: Allocation concealment (selection bias) , Low risk , Study reported that the only randomisation master code was held by the Bristol‐Myers Company. No investigator had access to randomisation codes until study termination.

Capsules:

Article Title: Antioxidants for chronic kidney disease
Article Snippet: Allocation concealment (selection bias) , Low risk , Study reported that the only randomisation master code was held by the Bristol‐Myers Company. No investigator had access to randomisation codes until study termination.



Similar Products

86
Bristol Myers randomisation master code
Randomisation Master Code, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/randomisation+master+code/code+master+randomisation/pmc10621004-1318-14-21
Average 86 stars, based on 1 article reviews
randomisation master code - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

Image Search Results